Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients
Stefanie Avril(Cornell University), Barbara Schmalfeldt(Universität Hamburg), Yasemin Dincer(Zentrum für Pränataldiagnostik), Alexander Hapfelmeier(Technical University of Munich), Karl‐Friedrich Becker(University of Bonn), Melanie Boxberg(Starnberg Hospital), Claudia Wolff(University of California, San Francisco), Sibylle Gündisch(Technical University of Munich), Katharina Malinowsky(Technical University of Munich), Holger Bronger(Technical University of Munich)
Cited by 33
Related Papers
Monogenic variants in dystonia: an exome-wide sequencing study
|The Lancet Neurology|2020|218
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
|Clinical Cancer Research|2012|124
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
|Gynecologic Oncology|2019|121